178 related articles for article (PubMed ID: 2109582)
1. In vitro investigation of BK-218, a new oral and parenteral cephalosporin.
Szabó I; Barabás J; Tar A; Kiss L; Filep M; Schmidt T; Marossy K; Tóth-Martinez B; Barabás G; Hernádi F
Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of the new orally active cephalosporin FK027.
Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H
J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
[TBL] [Abstract][Full Text] [Related]
3. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
Markus A; Klesel N; Wollmann T; Isert D; Limbert M; Schrinner E; Seibert G; Bauernfeind A; Jungwirth R; Wilhelm R
J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
Watanabe N; Katsu K; Moriyama M; Kitoh K
Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
[TBL] [Abstract][Full Text] [Related]
5. Penicillin-binding protein 5 as an inhibitory target of cefozopran in Enterococcus faecalis.
Tsuchimori N; Okonogi K
J Antimicrob Chemother; 1996 Mar; 37(3):605-9. PubMed ID: 9182117
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.
Wise R; Andrews JM; Ashby JP; Thornber D
Antimicrob Agents Chemother; 1990 May; 34(5):813-8. PubMed ID: 2360820
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
[TBL] [Abstract][Full Text] [Related]
8. Differences between ceftizoxime and its stereoisomer in antibacterial activity and affinity for penicillin-binding proteins.
Shigi Y; Kojo H; Wakasugi M; Nishida M
Antimicrob Agents Chemother; 1981 Mar; 19(3):393-6. PubMed ID: 7018389
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
[TBL] [Abstract][Full Text] [Related]
10. [Penicillin-binding proteins. Their enzymatic activity and properties].
Griaznova NS; Subbotina NA
Antibiot Med Biotekhnol; 1986 Jul; 31(7):487-98. PubMed ID: 3532933
[No Abstract] [Full Text] [Related]
11. [Cefdinir].
Soejima R
Jpn J Antibiot; 1992 Oct; 45(10):1239-52. PubMed ID: 1479675
[No Abstract] [Full Text] [Related]
12. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Utsui Y; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of NB2001 and NB2030, novel antibacterial agents activated by beta-lactamases.
Stone GW; Zhang Q; Castillo R; Doppalapudi VR; Bueno AR; Lee JY; Li Q; Sergeeva M; Khambatta G; Georgopapadakou NH
Antimicrob Agents Chemother; 2004 Feb; 48(2):477-83. PubMed ID: 14742198
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
[TBL] [Abstract][Full Text] [Related]
15. Affinities of cephalosporins for penicillin-binding proteins and their antibacterial activities in the presence of human serum albumin.
Fontana R; Ligozzi M; Cornaglia G
Clin Microbiol Infect; 2000; 6 Suppl 3():82-3. PubMed ID: 11449662
[No Abstract] [Full Text] [Related]
16. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial activity of cefpirome, a new cephalosporin.
Wise R; Andrews JM; Cross C; Piddock LJ
J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
Wise R; Andrews JM; Ashby JP; Thornber D
J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
Gootz T; Retsema J; Girard A; Hamanaka E; Anderson M; Sokolowski S
Antimicrob Agents Chemother; 1989 Aug; 33(8):1160-6. PubMed ID: 2679370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
